The invention relates to a group of compounds of formula (I) which contain a chromene nucleus and can inhibit lymphocyte proliferation owing to the TCR Nck interaction said invention also relating to the use of these compounds for the treatment of diseases or conditions in which the aforementioned interaction triggers a complication such as transplant rejection reactions immune or autoimmune diseases inflammatory diseases or proliferative diseases.